Low-level environmental lead exposure and children's intellectual function: an international pooled analysis.

PubWeight™: 10.66‹?› | Rank: Top 0.1%

🔗 View Article (PMC 1257652)

Published in Environ Health Perspect on July 01, 2005

Authors

Bruce P Lanphear1, Richard Hornung, Jane Khoury, Kimberly Yolton, Peter Baghurst, David C Bellinger, Richard L Canfield, Kim N Dietrich, Robert Bornschein, Tom Greene, Stephen J Rothenberg, Herbert L Needleman, Lourdes Schnaas, Gail Wasserman, Joseph Graziano, Russell Roberts

Author Affiliations

1: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA. bruce.lamphear@cchmc.org

Associated clinical trials:

HOME Study (Health Outcomes and Measures of the Environment Study) | NCT00129324

Articles citing this

(truncated to the top 100)

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Neurobehavioural effects of developmental toxicity. Lancet Neurol (2014) 6.27

Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect (2006) 3.56

Knowns and unknowns on burden of disease due to chemicals: a systematic review. Environ Health (2011) 3.27

Blood lead concentrations < 10 microg/dL and child intelligence at 6 years of age. Environ Health Perspect (2008) 2.81

Lead poisoning due to adulterated marijuana in leipzig. Dtsch Arztebl Int (2008) 2.72

Childhood lead poisoning: conservative estimates of the social and economic benefits of lead hazard control. Environ Health Perspect (2009) 2.44

A rationale for lowering the blood lead action level from 10 to 2 microg/dL. Neurotoxicology (2006) 2.41

Outbreak of fatal childhood lead poisoning related to artisanal gold mining in northwestern Nigeria, 2010. Environ Health Perspect (2011) 2.40

Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect (2006) 2.37

Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect (2006) 2.31

Associations of early childhood manganese and lead coexposure with neurodevelopment. Environ Health Perspect (2011) 2.31

Neuropsychological function in children with blood lead levels <10 microg/dL. Neurotoxicology (2007) 2.31

The relationship between early childhood blood lead levels and performance on end-of-grade tests. Environ Health Perspect (2007) 2.04

A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect (2011) 1.99

A review on the importance of metals and metalloids in atmospheric dust and aerosol from mining operations. Sci Total Environ (2012) 1.95

Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect (2010) 1.89

Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect (2007) 1.89

Association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood. PLoS Med (2008) 1.88

Low-level human equivalent gestational lead exposure produces sex-specific motor and coordination abnormalities and late-onset obesity in year-old mice. Environ Health Perspect (2008) 1.84

Decreased brain volume in adults with childhood lead exposure. PLoS Med (2008) 1.84

Age of greatest susceptibility to childhood lead exposure: a new statistical approach. Environ Health Perspect (2009) 1.82

A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environ Health Perspect (2007) 1.79

Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ Health Perspect (2009) 1.74

Modern environmental health hazards: a public health issue of increasing significance in Africa. Environ Health Perspect (2009) 1.74

Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health (2009) 1.74

Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control. Biol Psychiatry (2007) 1.53

Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics (2009) 1.52

Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ Health Perspect (2016) 1.50

Mass lead intoxication from informal used lead-acid battery recycling in dakar, senegal. Environ Health Perspect (2009) 1.47

Higher infant blood lead levels with longer duration of breastfeeding. J Pediatr (2009) 1.45

Association of environmental toxicants and conduct disorder in U.S. children: NHANES 2001-2004. Environ Health Perspect (2008) 1.45

The relationship between atmospheric lead emissions and aggressive crime: an ecological study. Environ Health (2016) 1.43

Cohort Profile: The China Jintan Child Cohort Study. Int J Epidemiol (2009) 1.43

Neurodevelopment in Early Childhood Affected by Prenatal Lead Exposure and Iron Intake. Medicine (Baltimore) (2016) 1.43

Elevated blood lead levels of children in Guiyu, an electronic waste recycling town in China. Environ Health Perspect (2007) 1.42

Effects of prenatal exposure to coal-burning pollutants on children's development in China. Environ Health Perspect (2008) 1.40

Environmental burden of disease in Europe: assessing nine risk factors in six countries. Environ Health Perspect (2014) 1.39

Confirmation and extension of association of blood lead with attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom domains at population-typical exposure levels. J Child Psychol Psychiatry (2009) 1.38

Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey. Arch Intern Med (2010) 1.37

Lead exposure, IQ, and behavior in urban 5- to 7-year-olds: does lead affect behavior only by lowering IQ? Pediatrics (2007) 1.36

Prenatal exposure to bisphenol A and phthalates and infant neurobehavior. Neurotoxicol Teratol (2011) 1.34

Secondhand tobacco smoke: a source of lead exposure in US children and adolescents. Am J Public Health (2011) 1.31

Lead exposure and behavior among young children in Chennai, India. Environ Health Perspect (2009) 1.31

Lead and mercury exposures: interpretation and action. CMAJ (2007) 1.30

Early childhood lead exposure and academic achievement: evidence from Detroit public schools, 2008-2010. Am J Public Health (2013) 1.30

The protean toxicities of lead: new chapters in a familiar story. Int J Environ Res Public Health (2011) 1.29

Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect (2009) 1.29

Economic benefits of methylmercury exposure control in Europe: monetary value of neurotoxicity prevention. Environ Health (2013) 1.26

Assuring access to data for chemical evaluations. Environ Health Perspect (2012) 1.25

Exposure of U.S. children to residential dust lead, 1999-2004: II. The contribution of lead-contaminated dust to children's blood lead levels. Environ Health Perspect (2008) 1.25

Low-level environmental lead exposure in childhood and adult intellectual function: a follow-up study. Environ Health (2011) 1.24

Potential hazard to human health from exposure to fragments of lead bullets and shot in the tissues of game animals. PLoS One (2010) 1.24

A cross-sectional study of well water arsenic and child IQ in Maine schoolchildren. Environ Health (2014) 1.23

Lead bullet fragments in venison from rifle-killed deer: potential for human dietary exposure. PLoS One (2009) 1.22

The important health impact of where a child lives: neighborhood characteristics and the burden of lead poisoning. Matern Child Health J (2011) 1.21

Maternal low-level lead exposure and fetal growth. Environ Health Perspect (2010) 1.20

Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Arch Gen Psychiatry (2009) 1.20

A framework for widespread replication of a highly spatially resolved childhood lead exposure risk model. Environ Health Perspect (2008) 1.20

Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed Res Int (2014) 1.18

European birth cohorts for environmental health research. Environ Health Perspect (2011) 1.16

Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci (2011) 1.16

Childhood lead exposure in France: benefit estimation and partial cost-benefit analysis of lead hazard control. Environ Health (2011) 1.15

Case-control study of blood lead levels and attention deficit hyperactivity disorder in Chinese children. Environ Health Perspect (2008) 1.14

Variants in iron metabolism genes predict higher blood lead levels in young children. Environ Health Perspect (2008) 1.14

Childhood lead poisoning: the torturous path from science to policy. J Clin Invest (2006) 1.13

The relationship between mental retardation and developmental delays in children and the levels of arsenic, mercury and lead in soil samples taken near their mother's residence during pregnancy. Int J Hyg Environ Health (2010) 1.13

Testing the dose-response specification in epidemiology: public health and policy consequences for lead. Environ Health Perspect (2005) 1.11

Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J (2012) 1.10

Probability of intellectual disability is associated with soil concentrations of arsenic and lead. Chemosphere (2011) 1.10

Lead in drinking water. CMAJ (2008) 1.09

Mechanisms of lead and manganese neurotoxicity. Toxicol Res (Camb) (2013) 1.09

Prenatal Exposures to Environmental Chemicals and Children's Neurodevelopment: An Update. Saf Health Work (2013) 1.08

Evolution of DOHaD: the impact of environmental health sciences. J Dev Orig Health Dis (2014) 1.08

Neurodevelopmental disorders: cluster 2 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med (2009) 1.08

Non-chemical stressors and cumulative risk assessment: an overview of current initiatives and potential air pollutant interactions. Int J Environ Res Public Health (2011) 1.07

The lead industry and lead water pipes "A Modest Campaign". Am J Public Health (2008) 1.07

Developmental neurotoxicants in e-waste: an emerging health concern. Environ Health Perspect (2010) 1.07

Low level environmental lead exposure--a continuing challenge. Clin Biochem Rev (2008) 1.06

Environmental contributors to the achievement gap. Neurotoxicology (2009) 1.05

Exposure of U.S. children to residential dust lead, 1999-2004: I. Housing and demographic factors. Environ Health Perspect (2008) 1.04

CNS effects of developmental Pb exposure are enhanced by combined maternal and offspring stress. Neurotoxicology (2008) 1.03

Lead and children: clinical management for family physicians. Can Fam Physician (2010) 1.03

Association of serum concentrations of persistent organic pollutants with the prevalence of learning disability and attention deficit disorder. J Epidemiol Community Health (2007) 1.02

Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence. Environ Health Perspect (2008) 1.02

Metal sources and exposures in the homes of young children living near a mining-impacted Superfund site. J Expo Sci Environ Epidemiol (2011) 1.00

Early life programming as a target for prevention of child and adolescent mental disorders. BMC Med (2014) 1.00

Ambient particulate matter and lung function growth in Chinese children. Epidemiology (2012) 0.99

Does the home environment and the sex of the child modify the adverse effects of prenatal exposure to chlorpyrifos on child working memory? Neurotoxicol Teratol (2012) 0.99

Alterations in glucocorticoid negative feedback following maternal Pb, prenatal stress and the combination: a potential biological unifying mechanism for their corresponding disease profiles. Toxicol Appl Pharmacol (2008) 0.99

Spatial analysis of learning and developmental disorders in upper Cape Cod, Massachusetts using generalized additive models. Int J Health Geogr (2010) 0.99

Blood lead levels and associated sociodemographic factors among preschool children in the South Eastern region of China. Paediatr Perinat Epidemiol (2011) 0.99

Early-life lead exposure results in dose- and sex-specific effects on weight and epigenetic gene regulation in weanling mice. Epigenomics (2013) 0.98

Hormesis and its place in nonmonotonic dose-response relationships: some scientific reality checks. Environ Health Perspect (2007) 0.98

Environmental lead exposure among preschool children in Shanghai, China: blood lead levels and risk factors. PLoS One (2014) 0.97

Children are likely to suffer most from our fossil fuel addiction. Environ Health Perspect (2008) 0.97

Blood lead levels of contemporary Japanese children. Environ Health Prev Med (2011) 0.96

Ethical issues in using children's blood lead levels as a remedial action objective. Am J Public Health (2011) 0.96

Interactions of lifetime lead exposure and stress: behavioral, neurochemical and HPA axis effects. Neurotoxicology (2010) 0.96

Environmental toxicity and poor cognitive outcomes in children and adults. J Environ Health (2014) 0.95

Articles cited by this

Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med (2003) 16.73

Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics (1992) 7.28

Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med (1987) 7.13

Low-level lead exposure and children's IQ: a meta-analysis and search for a threshold. Environ Res (1994) 7.05

The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med (1990) 6.72

Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep (2001) 6.12

Environmental lead and children's intelligence: a systematic review of the epidemiological evidence. BMJ (1994) 5.55

Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med (1992) 5.49

Low-level lead exposure and the IQ of children. A meta-analysis of modern studies. JAMA (1990) 5.30

Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med (2003) 5.18

Association of dental caries and blood lead levels. JAMA (1999) 3.32

Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain (2003) 3.23

The developmental consequences of low to moderate prenatal and postnatal lead exposure: intellectual attainment in the Cincinnati Lead Study Cohort following school entry. Neurotoxicol Teratol (1993) 3.13

Influence of blood lead on the ability and attainment of children in Edinburgh. Lancet (1987) 3.08

The paradox of lead poisoning prevention. Science (1998) 3.05

Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA (2003) 2.97

Lead exposure and intelligence in 7-year-old children: the Yugoslavia Prospective Study. Environ Health Perspect (1997) 2.88

Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol (2002) 2.66

The relationship between blood lead concentrations, intelligence and attainment in a school population: a pilot study. Dev Med Child Neurol (1981) 2.62

Absorption and retention of lead by infants. Pediatr Res (1978) 2.53

Intellectual impairment and blood lead levels. N Engl J Med (2003) 2.41

Condition and type of housing as an indicator of potential environmental lead exposure and pediatric blood lead levels. Environ Res (1985) 2.28

The Yugoslavia Prospective Study of environmental lead exposure. Environ Health Perspect (1999) 2.10

Low level lead exposure in the prenatal and early preschool periods: intelligence prior to school entry. Neurotoxicol Teratol (1989) 2.07

Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol (2002) 2.04

Picomolar concentrations of lead stimulate brain protein kinase C. Nature (1988) 2.02

Exposure to lead in children--how low is low enough? N Engl J Med (2003) 1.97

Lead and minor hearing impairment. Arch Environ Health (1991) 1.94

Identification of confounders in the assessment of the relationship between lead exposure and child development. Ann Epidemiol (2001) 1.93

Invited commentary: studies in mechanism and prevention. Striking a proper balance. Am J Epidemiol (1994) 1.93

Low-level lead exposure and cognitive function in children. Pediatr Ann (1994) 1.83

Lead-induced changes in learning: evidence for behavioral mechanisms from experimental animal studies. Neurotoxicology (1994) 1.73

Blood lead levels measured prospectively and risk of spontaneous abortion. Am J Epidemiol (1999) 1.61

Environmental lead exposure during early childhood. J Pediatr (2002) 1.56

Cognitive and sensorimotor functions in 6-year-old children in relation to lead and mercury levels: adjustment for intelligence and contrast sensitivity in computerized testing. Neurotoxicol Teratol (1998) 1.54

Natural skeletal levels of lead in Homo sapiens sapiens uncontaminated by technological lead. Sci Total Environ (1991) 1.44

Primary prevention of childhood lead poisoning--the only solution. N Engl J Med (2001) 1.39

Low-level exposures to lead: the Sydney lead study. Dev Med Child Neurol (1989) 1.28

Temporal pattern in the effect of postnatal blood lead level on intellectual development of young children. Neurotoxicol Teratol (2001) 1.28

Effects of low-level lead exposure on cell survival and neurite length in primary mesencephalic cultures. Neurotoxicol Teratol (2003) 1.22

Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity. Neurotoxicology (1997) 1.07

Articles by these authors

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29

In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93

Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50

Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03

Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45

Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet (2010) 5.12

Effect of a clinical trial alert system on physician participation in trial recruitment. Arch Intern Med (2005) 5.08

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06

Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71

Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69

Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke (2010) 3.56

Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol (2008) 3.54

Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol (2006) 3.53

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52

Recommendations for medical management of adult lead exposure. Environ Health Perspect (2006) 3.38

Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med (2012) 3.37

Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke (2007) 3.34

Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34

Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology (2005) 3.12

Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect (2006) 3.11

Exposure to environmental tobacco smoke and cognitive abilities among U.S. children and adolescents. Environ Health Perspect (2005) 3.07

Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation (2012) 3.02

Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke (2005) 3.00

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke (2004) 2.97

Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86

Intellectual impairment in school-age children exposed to manganese from drinking water. Environ Health Perspect (2010) 2.86

Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect (2010) 2.83

Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83

Blood lead concentrations < 10 microg/dL and child intelligence at 6 years of age. Environ Health Perspect (2008) 2.81

Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke (2011) 2.80

Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71

Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children. J Pediatr (2013) 2.67

Prenatal bisphenol A exposure and early childhood behavior. Environ Health Perspect (2009) 2.67

Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med (2012) 2.59

Prenatal exposure to organophosphates, paraoxonase 1, and cognitive development in childhood. Environ Health Perspect (2011) 2.56

The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke (2006) 2.56

US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke (2009) 2.54

Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol (2006) 2.54

Related causal frameworks for surrogate outcomes. Biometrics (2009) 2.46

Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics (2011) 2.44

Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42

Intellectual impairment and blood lead levels. N Engl J Med (2003) 2.41

High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis (2003) 2.41

Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect (2006) 2.37

A randomized controlled trial of home injury hazard reduction: the HOME injury study. Arch Pediatr Adolesc Med (2011) 2.36

Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke (2002) 2.36

Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics (2010) 2.35

The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34

A quantitative risk-benefit analysis of changes in population fish consumption. Am J Prev Med (2005) 2.33

Industry testing of toxic pesticides on human subjects concluded "no effect," despite the evidence. Environ Health Perspect (2004) 2.32

Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect (2006) 2.31

Associations of early childhood manganese and lead coexposure with neurodevelopment. Environ Health Perspect (2011) 2.31

Neuropsychological function in children with blood lead levels <10 microg/dL. Neurotoxicology (2007) 2.31

Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension (2008) 2.24

Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21

Longitudinal associations between blood lead concentrations lower than 10 microg/dL and neurobehavioral development in environmentally exposed children in Mexico City. Pediatrics (2006) 2.17

Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int (2004) 2.16

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13

The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg (2003) 2.12

Effect of frequent hemodialysis on residual kidney function. Kidney Int (2013) 2.10

Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol (2005) 2.07

Associations of maternal long-chain polyunsaturated fatty acids, methyl mercury, and infant development in the Seychelles Child Development Nutrition Study. Neurotoxicology (2008) 2.06

Community socioeconomic status and prehospital times in acute stroke and transient ischemic attack: do poorer patients have longer delays from 911 call to the emergency department? Stroke (2006) 2.00

Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother (2013) 1.99

Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children. Arch Pediatr Adolesc Med (2012) 1.98

Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol (2005) 1.97

Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96

Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics (2004) 1.92

Infant feeding and childhood cognition at ages 3 and 7 years: Effects of breastfeeding duration and exclusivity. JAMA Pediatr (2013) 1.92

Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol (2010) 1.92

Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90

Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect (2007) 1.89

Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88

Association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood. PLoS Med (2008) 1.88

The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol (2013) 1.87

Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment. Stroke (2009) 1.86